News

Member Portal

American Health Packaging on Behalf of BluePoint Laboratories Issues Recall forPotassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due toFailed Dissolution

June 25, 2024

Glenmark Pharmaceuticals Inc., USA Issues Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution

June 24, 2024

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

By submitting this form, you are consenting to receive marketing emails from: Benecard Services, LLC. (Lawrenceville, NJ 08648), https://www.benecard.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.

News

GENERIC DRUG APPROVALS

NYPOZI

AHZANTIVE®

TEPYLUTE

American Health Packaging on Behalf of BluePoint Laboratories Issues Recall forPotassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due toFailed Dissolution

Glenmark Pharmaceuticals Inc., USA Issues Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution

PiaSky

SOFDRA™

YIMMUGO

Benefit Advisors & Employees - Want to know more?

Benecard

Newsletter